Stockreport

Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]

Ikena Oncology, Inc.  (IKNA) 
PDF IK-930 clinical update planned for 2H 2024 including additional data from EHE patients in dose escalation and initial mesothelioma patient data IK-595 Phase I dose es [Read more]